INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

Azienda Ospedaliera Universitaria San Luigi Gonzaga Orbassano, Orbassano

Weill Cornell Medical Centers, New York

Institut Paoli Calmettes, Marseille

Azienda Ospedaliera Papa Giovanni Xxiii, Bergamo

Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo, Pavia

Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham

Emory University - Winship Cancer Institute, Atlanta

Emory University-Winship Cancer Institute, Atlanta

Vanderbilt University Medical Center, Nashville

S Orsolas University Hospital Seragnoli Institute of Hematology, Bologna

Centre Hospitalier D'Angers, Angers

Start Midwest, Grand Rapids

Azienda Ospedaliero-Universitaria Careggi (Aouc), Florence

Washington University School of Medicine, St Louis

Hospital Saint Louis, Paris

Md Anderson Cancer Center, Houston

Usc Norris Comprehensive Cancer Center, Los Angeles

City of Hope National Medical Center, Duarte

Prebys Cancer Center, San Diego

City of Hope Orange County, Irvine

Stanford Cancer Center, Palo Alto

Princess Margaret Cancer Center, Toronto

McGill University Jewish General Hospital, Montreal

Ospedale Santa Maria Della Misericordia Perugia, Perugia

Tokyo Medical and Dental University Hospital, Bunkyō City

Chiba Cancer Center, Chiba

Gifu Municipal Hospital, Gifu

Kansai Medical University Hospital, Hirakata

Kumamoto Shinto General Hospital, Kumamoto

Osaka International Cancer Institute, Osaka

University Hospital of Wales, Cardiff

United Lincolnshire Hospitals, Boston

Lincoln County Hospital, Lincoln

Royal Cornwall Hospital Truro Sunrise Centre, Truro